Loading…

Blue Light Laser Results in Less Vocal Fold Scarring Compared to KTP Laser in Normal Rat Vocal Folds

Objectives Preliminary investigations suggest that a novel blue light (BL) laser with a wavelength of 445 nm is comparable to the commonly utilized potassium titanyl phosphate (KTP) laser (532 nm) for treatment of various laryngeal pathologies. The objective of the current study is to make a direct...

Full description

Saved in:
Bibliographic Details
Published in:The Laryngoscope 2021-04, Vol.131 (4), p.853-858
Main Authors: Lin, R. Jun, Iakovlev, Vladimir, Streutker, Catherine, Lee, Daniel, Al‐Ali, Mohammed, Anderson, Jennifer
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives Preliminary investigations suggest that a novel blue light (BL) laser with a wavelength of 445 nm is comparable to the commonly utilized potassium titanyl phosphate (KTP) laser (532 nm) for treatment of various laryngeal pathologies. The objective of the current study is to make a direct histological comparison of the degree of vocal fold scarring after either BL or KTP laser treatment in an animal model. Study Design This was a randomized controlled study using rats. Methods Twenty‐four Sprague–Dawley rats were randomized to BL or KTP laser treatment. Laser was delivered in non‐overlapping pulses to normal rat vocal folds. Larynges in each group were harvested at three time points: post‐operative day 1, 30, and 90. Three animals served as negative controls. The excised whole larynges were sectioned transversely and stained with hematoxylin/eosin and trichrome. Presence of subepithelial inflammation and protein deposition/fibrosis indicative of scarring were scored semi‐quantitatively (from grade 1–3) by two pathologists blinded to treatment groups. Results Between‐group comparison showed that both laser treatments resulted in significantly elevated subepithelial protein deposition/fibrosis 90 days after treatment compared to negative controls (BL: 2 ± 0; KTP: 2.67 ± 0.29; control: 1.17 ± 0.29; P
ISSN:0023-852X
1531-4995
DOI:10.1002/lary.28892